Soy isoflavones could improve endothelial function: Study

By Nathan Gray

- Last updated on GMT

Related tags: Blood vessel, Endothelium, Soybean

Supplementation with soy isoflavones could improve blood vessel endothelial cell function and reduce cardiovascular disease risk factors, according a new meta-analysis study.

The research, published in the journal Nutrition, Metabolism and Cardiovascular Diseases​, analyzed 17 studies on the effect of isoflavones on endothelial function, finding a small but valuable benefit from isoflavone supplementation.

“Cumulative evidence from the randomised controlled trials included in this meta-analysis suggests that exposure to soy isoflavones can modestly, but significantly, improve endothelial function as measured by flow mediated dilation,”​ reported the researchers.

Heart risk

Soy foods have been shown to reduce cholesterol levels, with recent evidence suggesting that isoflavones could reduce other cardiovascular disease (CVD) risk factors, such as blood pressure and endothelial function.

Cardiovascular disease affects one in three Americans, and is a leading cause or mortality globally.

Endothelial dysfunction signifies the early stages of heart disease and is s a predictive marker for long-term CVD and mortality.

Flow-mediated dilation (FMD) of brachial artery is used as an assessment tool for endothelial function. Impaired FMD response is a CVD risk factor and can precede clinically symptomatic CVD by many years.

The new research is a meta-analysis of 17 randomised controlled trials (RCT) aimed to determine whether exposure to isoflavone-containing soy products affects endothelial function.

Significant results

Out of 42 trials initially found from a comprehensive literature search, 17 were selected as having sufficient data for study inclusion.

Seven of the 17 studies reported statistically significant changes in endothelial function as measured by FMD. Researchers suggested that several several other studies reporting no effects may have used too small of a study population to gain significant results.

The meta-analysis found the overall change in FMD for isoflavone-containing soy product interventions to be 1.15 percent.

When the effects of separate interventions were considered, treatment effects for isolated isoflavones were 1.98 percent compared with 0.72 percent for isoflavone-containing soy protein, reported the study.

The significant improvement in FMD observed in response to isolated isoflavone exposure is within the range deemed clinically relevant, “thereby indicating that exposure to isoflavone supplements may beneficially influence vascular health,”​ added the authors.

Researchers stated the key mechanism behind endothelial dysfunction involves the impaired release of nitric oxide (NO), causing blood vessels to constrict. Increased availability of isoflavone is suggested to increase NO production.

Confirmation needed

Though the meta-analysis finds a significant increase in endothelial function from supplementation with isoflavones, the researchers believe their results “warrant confirmation from a large, prospective, RCT.”

​Researchers indicated that future trials and observational studies should also attempt to detect dose-response effects: “Ideally, it would be desirable to test the hypothesis that larger doses of soy isoflavone supplementation yield greater responses in FMD”

Source:​Nutrition, Metabolism and Cardiovascular Diseases

Published online ahead of print, doi: 10.1016/j.numecd.2010.05.007

“Exposure to isoflavone-containing soy products and endothelial function: A Bayesian meta-analysis of randomized controlled trials”

Authors: D.P. Beavers, K.M. Beavers, M. Miller, J. Stamey, M.J. Messina

Related news

Show more

Related products

show more

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars